Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26177 | 215 | 25.0 | 49% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2487 | 3478 | ELAFIN//SLPI//SECRETORY LEUKOCYTE PROTEASE INHIBITOR |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | NAFAMOSTAT MESILATE | Author keyword | 13 | 36% | 14% | 30 |
| 2 | PHARM PHARMACEUT HIGASHINADA KU | Address | 3 | 100% | 1% | 3 |
| 3 | MED HOSP PHARM CHUO KU | Address | 3 | 35% | 3% | 6 |
| 4 | 6 AMIDINO 2 NAPHTHOL | Author keyword | 2 | 67% | 1% | 2 |
| 5 | P GUANIDINOBENZOIC ACID | Author keyword | 2 | 67% | 1% | 2 |
| 6 | COLLECTING DUCT CELL | Author keyword | 2 | 50% | 1% | 3 |
| 7 | NAFAMOSTAT | Author keyword | 2 | 27% | 3% | 6 |
| 8 | SODIUM BISULFITE SBS | Author keyword | 1 | 100% | 1% | 2 |
| 9 | CELITE ACTIVATED COAGULATION TIME | Author keyword | 1 | 50% | 0% | 1 |
| 10 | FUT 187 | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NAFAMOSTAT MESILATE | 13 | 36% | 14% | 30 | Search NAFAMOSTAT+MESILATE | Search NAFAMOSTAT+MESILATE |
| 2 | 6 AMIDINO 2 NAPHTHOL | 2 | 67% | 1% | 2 | Search 6+AMIDINO+2+NAPHTHOL | Search 6+AMIDINO+2+NAPHTHOL |
| 3 | P GUANIDINOBENZOIC ACID | 2 | 67% | 1% | 2 | Search P+GUANIDINOBENZOIC+ACID | Search P+GUANIDINOBENZOIC+ACID |
| 4 | COLLECTING DUCT CELL | 2 | 50% | 1% | 3 | Search COLLECTING+DUCT+CELL | Search COLLECTING+DUCT+CELL |
| 5 | NAFAMOSTAT | 2 | 27% | 3% | 6 | Search NAFAMOSTAT | Search NAFAMOSTAT |
| 6 | SODIUM BISULFITE SBS | 1 | 100% | 1% | 2 | Search SODIUM+BISULFITE+SBS | Search SODIUM+BISULFITE+SBS |
| 7 | CELITE ACTIVATED COAGULATION TIME | 1 | 50% | 0% | 1 | Search CELITE+ACTIVATED+COAGULATION+TIME | Search CELITE+ACTIVATED+COAGULATION+TIME |
| 8 | FUT 187 | 1 | 50% | 0% | 1 | Search FUT+187 | Search FUT+187 |
| 9 | HIGH BLEEDING RISK | 1 | 50% | 0% | 1 | Search HIGH+BLEEDING+RISK | Search HIGH+BLEEDING+RISK |
| 10 | IN VIVO APPROACH | 1 | 50% | 0% | 1 | Search IN+VIVO+APPROACH | Search IN+VIVO+APPROACH |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FUT 175 | 14 | 43% | 12% | 26 |
| 2 | NAFAMSTAT MESILATE | 5 | 42% | 5% | 10 |
| 3 | FACTOR EGF OINTMENT | 4 | 75% | 1% | 3 |
| 4 | SYNTHETIC PROTEASE INHIBITOR | 3 | 23% | 5% | 11 |
| 5 | MESILATE | 2 | 19% | 5% | 11 |
| 6 | NAFAMOSTAT | 2 | 40% | 2% | 4 |
| 7 | FUT 175 NAFAMSTAT MESILATE | 1 | 100% | 1% | 2 |
| 8 | K TRANSPORT PROPERTIES | 1 | 33% | 1% | 2 |
| 9 | DUSTING METHOD | 1 | 50% | 0% | 1 |
| 10 | HUMAN FACTOR B | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| INVERSE SUBSTRATES FOR TRYPSIN AND TRYPSIN-LIKE ENZYMES | 1987 | 15 | 16 | 69% |
| Mechanisms of hyperkalemia caused by nafamostat mesilate | 1995 | 12 | 18 | 50% |
| Transcriptional regulation and environmental induction of gene encoding copper- and zinc-containing superoxide dismutase | 2002 | 14 | 20 | 20% |
| Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma | 2007 | 4 | 19 | 21% |
| ACYL-ENZYMES AS PRODRUGS | 1989 | 5 | 14 | 36% |
| NAFAMOSTAT MESILATE | 1995 | 24 | 44 | 16% |
| DEVELOPMENT OF INVERSE SUBSTRATES FOR TRYPSIN - APPLICATION TO THE STUDIES ON THE STRUCTURE AND FUNCTION OF ENZYME AND TO THE DESIGN FOR BIOLOGICALLY-ACTIVE COMPOUNDS | 1985 | 0 | 15 | 87% |
| DESIGN OF BIOSPECIFIC COMPOUNDS WHICH SIMULATE ENZYME-SUBSTRATE INTERACTION | 1986 | 1 | 29 | 38% |
| Redox-Mediated Gene Therapies for Environmental Injury: Approaches and Concepts | 1999 | 29 | 145 | 1% |
| APPROACHES TO SYNTHESIS OF SPECIFIC INHIBITORS OF ENZYME | 1987 | 2 | 147 | 3% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PHARM PHARMACEUT HIGASHINADA KU | 3 | 100% | 1.4% | 3 |
| 2 | MED HOSP PHARM CHUO KU | 3 | 35% | 2.8% | 6 |
| 3 | MED GASTROENTEROL METAB | 1 | 50% | 0.5% | 1 |
| 4 | MINATO KU MED | 1 | 50% | 0.5% | 1 |
| 5 | HOSP PHARM TSUKINOWA CHO | 0 | 33% | 0.5% | 1 |
| 6 | MOL CELL ONCOL | 0 | 33% | 0.5% | 1 |
| 7 | HAMURA | 0 | 25% | 0.5% | 1 |
| 8 | ORGAN TRANSPLANTAT REGENERAT MEDKITA KU | 0 | 25% | 0.5% | 1 |
| 9 | GENE THER YMINATO KU | 0 | 11% | 0.9% | 2 |
| 10 | PHARMACEUT TECHNOL DEV S | 0 | 20% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000116289 | COMPSTATIN//COBRA VENOM FACTOR//STELLAR CHANCE S 401 |
| 2 | 0.0000102998 | ALLIED MED SCI SUMA KU//MED FUKUSHIMA KU//TARUMI KU |
| 3 | 0.0000094580 | MUCOPOLYSACCHARIDE POLYSULFATE//CAS 530 78 9//PERFUSED PIG EAR |
| 4 | 0.0000077992 | PLASMINOGEN INHIBITOR//STATE NAT MEDJIANGSU CARCINOGENE//TPA MRNA |
| 5 | 0.0000071597 | MERBARONE//SEZ CHIM FARMACO PRODOTTO COSMET//SQUAMOUS CELL CARCINOMA CERVIX |
| 6 | 0.0000069588 | MNCF//NEUTROPHIL MIGRATION INHIBITION//NEUTROPHIL RECRUITMENT INHIBITORY FACTOR |
| 7 | 0.0000068774 | REGIONAL CITRATE ANTICOAGULATION//REGIONAL ANTICOAGULATION//CITRATE ANTICOAGULATION |
| 8 | 0.0000065328 | MURINE MODELS OF SLE//LI AND NZB W MICE//LI AND RENAL DISEASE |
| 9 | 0.0000055593 | PHARM MICROBIOL TENPAKU KU//AGR VET MED VET MICROBIOL//PICTORIAL MANUSCRIPTS |
| 10 | 0.0000051182 | ENDOGENOUS ANTIOXIDANT DEFENCE//MELON EXTRACT//ORGOTEIN |